SLC47A2 and neoplasm: Nevertheless, the existence of a weak statistical association between MATE2 expression and the anti-proliferative effect of metformin suggests that tumor MATE2 expression should be evaluated as a potential biomarker of response in ongoing clinical trials that are investigating the effects of metformin on tumor (re)growth.